Marker Test Diagnostics, an international supplier to the drug testing
industry, announced today that representatives from the company will
attend the 2014 American Association for Clinical Chemistry (AACC)
Annual Meeting July 27 - 31 at McCormick Place in Chicago, IL. The
company will attend the conference to promote the development and U.S.
expansion for UR Code™, an oral marker developed by Marker Test that
"bar-codes" a subject's urine and eliminates the need to supervise urine
In the form of a soft gel capsule, UR Code provides an accurate, secure
and cost-effective answer to common drug testing challenges by:
Immediately following the conference on August 1, Marker Test will
distribute a Request for Proposals (RFP) to laboratories that responded
to an earlier RFI to compete for consideration for "exclusivity" to
market and sell the UR Code product in the United States.
For more details about the AACC Conference or to make an appointment to
meet with representatives from Marker Test, contact email@example.com.
About Marker Test Diagnostics
Founded in 2013, Marker Test Diagnostics is the producer of UR Code
(TM), an innovative oral marker for the drug testing market. Marker Test
Diagnostics is currently conducting research studies in the field of
addiction and sport and collaborates with the Olympic Doping Laboratory
at the UCLA and a renowned research university. For more information
about Marker Test Diagnostics, visit www.markertest.com.
[ Back To NFVZone's Homepage ]